Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare
Vaxcyte, Inc. Total Liabilities 2020–2025
Vaxcyte, Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Vaxcyte, Inc. total liabilities as of December 31, 2025: 317.2M, a 54.36% increase year-over-year.
- Vaxcyte, Inc. total liabilities for 2025 were 317.2M, a 54.36% increase from 2024.
- Vaxcyte, Inc. total liabilities for 2024 were 205.5M, a 22.72% increase from 2023.
- Vaxcyte, Inc. total liabilities for 2023 were 167.4M, a 218.56% increase from 2022.
- Vaxcyte, Inc. total liabilities for 2022 were 52.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vaxcyte, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $317 |
| 2024 | $205 |
| 2023 | $167 |
| 2022 | $53 |
| 2021 | $40 |
| 2020 | $47 |
Vaxcyte, Inc. Total Liabilities — FAQ
Vaxcyte, Inc. (PCVX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCVX's total liabilities history?
The chart and table above show Vaxcyte, Inc.'s total liabilities by year and by quarter, including the growth rate.